Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Dezhi LiXianyi ChengWei V ZhengJunhui ChenPublished in: Cancer management and research (2020)
The results of this study suggest that GNPDA1 may serve as a novel prognostic biomarker and therapeutic target for HCC.
Keyphrases